Oruka Therapeutics, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Oruka Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $4.30M.
- Oruka Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $1.77M.
- Oruka Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-09-30 was -$427.00K.
- Oruka Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-06-30 was $14.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $4.30M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $1.77M 10-Q · filed 2026-08-10 | |
| 2024-09-30 | -$427.00K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $14.00K 10-Q · filed 2024-08-01 | |
| 2014-03-31 | $318.00K 10-Q · filed 2014-05-13 | |
| 2010-12-31 | $139.00K 10-Q · filed 2014-05-13 | |
| 2009-12-31 | $114.00K 10-Q · filed 2014-05-13 | |
| 2008-12-31 | $54.00K 10-Q · filed 2014-05-13 | |
| 2007-12-31 | $16.00K 10-Q · filed 2014-05-13 | |
| 2006-12-31 | $3.00K 10-Q · filed 2014-05-13 | |
| 2005-12-31 | $44.00K 10-Q · filed 2012-08-13 | |
| 2004-12-31 | $7.00K 10-Q · filed 2012-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Veradermics, Inc (MANE) | United States | $4.839B |